You are here: Industry Insights > Vaccine

News List

COVID-19 Clinical Trials contractpharma
March 11, 2020
The vaccines in development for COVID-19, who's developing them, and where they stand in the development process.
Arcturus Therapeutics partners with medical school for coronavirus vaccine pharmaceutical-technology
March 09, 2020
Arcturus Therapeutics, a RNA medicines company, and Duke-NUS Medical School have partnered to develop a coronavirus Covid-19 vaccine for Singapore.
Thin film platform to preserve vaccines at room temperature developed europeanpharmaceuticalreview
March 06, 2020
A new vaccine formulation has been created by researchers, which uses a peelable film during drying to preserve the medicine.
Viroclinics and DDL Join Forces contractpharma
March 04, 2020
Two virology testing laboratories integrate to form new group serving the global biopharmaceutical industry.
Novavax starts animal testing of coronavirus vaccine candidates pharmaceutical-technology
March 03, 2020
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models.
Novavax Advances Development of COVID-19 Vaccine contractpharma
March 03, 2020
Novavax, Inc., a late-stage biotechnology company developing next-gen vaccines for serious infectious diseases, has advanced its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19.
WuXi Biologics’ Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader Wuxi Biologics
February 19, 2020
WuXi Vaccines has entered into a strategic partnership with a global vaccine leader and signed a 20-year vaccine manufacturing contract valued approximately $3 billion USD.
Young Adults Who Ever Received HPV Vaccine on the Rise drugs
January 20, 2020
From 2013 to 2018, there was an increase in the percentage of adults aged 18 to 26 years who received one or more doses or the recommended number of doses of human papillomavirus (HPV) vaccine ...
Universal Flu Vaccine Works in Mice drugs
January 16, 2020
An experimental flu vaccine gave mice long-lasting protection against six different flu virus strains, researchers report. The nanoparticle vaccine contains two major influenza proteins -- matrix protein 2 ectodomain (M2e), and neuraminidase (NA) ...
Global neoantigen cancer vaccine market to generate $1,826.1m revenue by 2030 europeanpharmaceuticalreview
January 16, 2020
A study suggests the global neoantigen cancer vaccine market will grow exponentially due to expected drug launches, new technology reducing costs and currently unmet needs of the market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page